XML 21 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Unaudited Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Sales, net $ 17,259 $ 14,683
Cost of sales 6,727 5,449
Gross profit 10,532 9,234
Operating expenses:    
Sales and marketing 8,237 6,258
Research and development 1,078 787
General and administrative 8,949 9,551
Total operating expenses 18,264 16,596
Operating loss (7,732) (7,362)
Interest expense, net (8) (19)
Net loss $ (7,740) $ (7,381)
Basic loss per common share (in dollars per share) $ (0.11) $ (0.12)
Diluted loss per common share (in dollars per share) $ (0.11) $ (0.12)
Basic weighted average common shares outstanding (in shares) 68,314 64,164
Diluted weighted average common shares outstanding (in shares) 68,314 64,164